Chronic Bronchitis

Chronic Bronchitis Treatment

Stem Cell Treatment for Patients with Chronic Bronchitis

The Lung Institute is proud to offer alternative treatment options for patients with chronic bronchitis, which is one of the most prominent conditions that make up chronic obstructive pulmonary disease (COPD). We understand that dealing with chronic bronchitis can often seem overwhelming to the person affected, and our caring staff is here to help. We provide alternative treatments for chronic bronchitis that have helped many people return to their favorite activities. Specifically, we offer two forms of stem cell therapy, which can potentially slow the progression of lung disease and improve a patient’s quality of life.

Our minimally invasive stem cell treatment options for patients with chronic bronchitis include:

  • Blood (venous) stem cell therapy ­– Venous procedures involve deriving stem cells from a patient’s own blood. This relatively quick and simple procedure entails drawing blood, isolating the stem cells in our onsite lab and returning the stem cells to the patient’s body intravenously to promote the body’s natural healing processes.
  • Bone marrow stem cell therapy – This procedure involves taking a small amount of a patient’s bone marrow fluid, separating the stem cells from the other cells and then intravenously reintroducing the stem cells to the patient’s body to help stimulate the body’s natural repair response.

Both procedures are performed in an outpatient setting over the course of two days. Our devoted medical staff works closely with patients living with chronic bronchitis to develop an optimal treatment plan that meets their specific needs. More than 80 percent of patients report seeing improvement in their quality of life following treatment at the Lung Institute, the only stem cell clinic in the world focusing exclusively on treating lung disease.

To learn more about our stem cell treatment options available to chronic bronchitis patients, contact the Lung Institute today at (800) 729-3065. Our caring team is ready to discuss how stem cell therapy could help you get back to enjoying life.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.